Evidence map›Paper›PMID 33105052›Full record

ArticleInternational journal of cancer2021

Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium.

Susan J Jordan, Renhua Na, Elisabete Weiderpass, Hans-Olov Adami, Kristin E Anderson, Piet A van den Brandt, Louise A Brinton, Chu Chen, Linda S Cook, Jennifer A Doherty and 40 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors at 20 institutions in 10 countries.

Susan J JordanPopulation Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0002-4566-1414
Renhua NaPopulation Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0002-9830-8462
Elisabete WeiderpassDirector's Office, International Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID 0000-0003-2237-0128
Hans-Olov AdamiDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Kristin E AndersonSchool of Public Health, Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0002-5158-5681
Piet A van den BrandtDepartment of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0001-8781-8099
Louise A BrintonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.ORCID 0000-0003-3853-8562
Chu ChenDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.ORCID 0000-0003-2267-8050
Linda S CookDivision of Epidemiology, Biostatistics & Preventive Medicine, Department of Internal Medicine, NM Health Sciences Center, University of New Mexico, University of New Mexico, Albuquerque, New Mexico, USA.ORCID 0000-0002-7917-0082
Jennifer A DohertyDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.ORCID 0000-0002-1454-8187
Mengmeng DuDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Christine M FriedenreichDepartment of Cancer Epidemiology and Prevention Research, Cancer Care Alberta, Alberta Health Services, Calgary, Alberta, Canada.ORCID 0000-0002-4783-1966
Gretchen L GierachIntegrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.ORCID 0000-0002-0165-5522
Marc T GoodmanCancer Prevention and Control Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Vittorio KroghEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.ORCID 0000-0003-0122-8624
Fabio LeviDepartment of Epidemiology and Health Services Research, Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Lingeng LuDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.ORCID 0000-0001-9871-0809
Anthony B MillerEpidemiology Division, Dalla Lana School of Public Health, Toronto, Ontario, Canada.ORCID 0000-0001-5174-3515
Susan E McCannDepartment of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.ORCID 0000-0002-2079-8705
Kirsten B MoysichDepartment of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Eva NegriDepartment of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0001-9712-8526
Sara H OlsonDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Stacey PetruzellaDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Julie R PalmerSlone Epidemiology Center at Boston University, Boston, Massachusetts, USA.ORCID 0000-0002-6534-335X
Fabio ParazziniDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Malcolm C PikeDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.ORCID 0000-0003-4891-1199
Anna E PrizmentScreening, Prevention, Etiology and Cancer Survivorship Program, University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, USA.
Timothy R RebbeckDivision of Population Science, Dana-Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.
Peggy ReynoldsDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-5783-7536
Fulvio RicceriDepartment of Clinical and Biological Sciences, University of Turin, Orbassano, Italy.ORCID 0000-0001-8749-9737
Harvey A RischDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
Thomas E RohanDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.ORCID 0000-0002-8008-5096
Leo J SchoutenDepartment of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0003-3361-7560
Diego SerrainoCancer Epidemiology Unit, Centro di Riferimento Oncologico IRCCS, Aviano, Italy.ORCID 0000-0003-0565-8920
Veronica W SetiawanDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.ORCID 0000-0001-9239-5692
Xiao-Ou ShuDivision of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.ORCID 0000-0002-0711-8314
Todd R SponholtzSlone Epidemiology Center at Boston University, Boston, Massachusetts, USA.
Amanda B SpurdlePopulation Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0003-1337-7897
Rachael Z Stolzenberg-SolomonMetabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.ORCID 0000-0003-3698-7006
Britton TrabertMetabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.ORCID 0000-0002-1539-6090
Nicolas WentzensenDivision of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, Bethesda, Maryland, USA.ORCID 0000-0003-1251-0836
Lynne R WilkensEpidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Lauren A WiseDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0003-2138-3752
Herbert YuEpidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.ORCID 0000-0003-3950-4815
Carlo La VecchiaDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0003-1441-897X
Immaculata De VivoDepartment of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-7185-7402
Wanghong XuDepartment of Epidemiology, Fudan University School of Public Health, Shanghai, China.ORCID 0000-0003-2045-2218
Anne Zeleniuch-JacquotteDepartment of Population Health and Perlmutter Cancer Center, New York University Langone Health, New York, New York, USA.ORCID 0000-0001-9350-1303
Penelope M WebbPopulation Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0003-0733-5930
National Cancer Institute · USMemorial Sloan Kettering Cancer Center · USBoston University · USUniversity of Milan · ITMaastricht University · NLQIMR Berghofer Medical Research Institute · AURoswell Park Comprehensive Cancer Center · USThe University of Queensland · AUUniversity of Hawaiʻi at Mānoa · USUniversity of Minnesota · USYale University · USAlberta Health Services · CAAlbert Einstein College of Medicine · USBrigham and Women's Hospital · USCedars-Sinai Medical Center · USCentre international de recherche sur le cancer · FRCentre universitaire de médecine générale et santé publique, Lausanne · CHCentro di Riferimento Oncologico · ITDana-Farber Cancer Institute · USFondazione IRCCS Istituto Nazionale dei Tumori · IT

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MYLES G COCKBURN · 1985 to 2026
$181.4M
Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ROSNER, BERNARD A · 2000 to 2019
$77.8M
WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
University of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GERTRAUD MASKARINEC · 1996 to 2026
$56.2M
Understanding Population Differences in Cancer: The MEC StudyU01CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HAIMAN, CHRISTOPHER ALAN, LE MARCHAND, LOIC · 2015 to 2025
$37.4M
CALIFORNIA TEACHERS STUDYR01CA077398 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERNSTEIN, LESLIE · 1998 to 2014
$29.7M
RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZELIKOFF, JUDITH TERRY · 1985 to 2020
$26.1M
A Follow-up Study for Causes of Cancer in Black WomenU01CA164974 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Kimberly A. Bertrand, Yvette C Cozier · 2017 to 2026
$24.0M
Intramural NIH HHS Z99 CA999999NCATS NIH HHS UL1 TR001863NCI NIH HHS 2R01 CA082838NCI NIH HHS CA11535NCI NIH HHS K05 CA092002NCI NIH HHS N01-CN-05223NCI NIH HHS N01-CN-55424NCI NIH HHS P01 CA033619NCI NIH HHS P01 CA077596NCI NIH HHS P01 CA087969NCI NIH HHS P01-CA77596NCI NIH HHS P01 CA87969NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA014089NCI NIH HHS P30 CA016056NCI NIH HHS P30CA016056NCI NIH HHS P30 CA016087NCI NIH HHS P30 CA071789NCI NIH HHS P30 CA118100NCI NIH HHS P30CA118100NCI NIH HHS P30 CA14089NCI NIH HHS R01 CA039742NCI NIH HHS R01 CA047749NCI NIH HHS R01 CA048737NCI NIH HHS R01 CA058420NCI NIH HHS R01 CA058598NCI NIH HHS R01 CA077398NCI NIH HHS R01 CA081212NCI NIH HHS R01 CA082838NCI NIH HHS R01 CA083918NCI NIH HHS R01 CA087538NCI NIH HHS R01 CA092585NCI NIH HHS R01 CA098346NCI NIH HHS R01 CA105212NCI NIH HHS R01 CA39742NCI NIH HHS R01 CA47749NCI NIH HHS R01 CA48774NCI NIH HHS R01 CA75977NCI NIH HHS R01 CA77398NCI NIH HHS R03 CA096400NCI NIH HHS R03 CA135632NCI NIH HHS R03 CA169888NCI NIH HHS R35 CA39779NCI NIH HHS U01 CA164973NCI NIH HHS U01 CA164974NCI NIH HHS U01 CA182934NICHD NIH HHS N01 HD023166NIEHS NIH HHS P30 ES000260NIH HHS R01 CA74877World Health Organization 001
6 · The paper itself

Abstract

A full-term pregnancy is associated with reduced endometrial cancer risk; however, whether the effect of additional pregnancies is independent of age at last pregnancy is unknown. The associations between other pregnancy-related factors and endometrial cancer risk are less clear. We pooled individual participant data from 11 cohort and 19 case-control studies participating in the Epidemiology of Endometrial Cancer Consortium (E2C2) including 16 986 women with endometrial cancer and 39 538 control women. We used one- and two-stage meta-analytic approaches to estimate pooled odds ratios (ORs) for the association between exposures and endometrial cancer risk. Ever having a full-term pregnancy was associated with a 41% reduction in risk of endometrial cancer compared to never having a full-term pregnancy (OR = 0.59, 95% confidence interval [CI] 0.56-0.63). The risk reduction appeared the greatest for the first full-term pregnancy (OR = 0.78, 95% CI 0.72-0.84), with a further ~15% reduction per pregnancy up to eight pregnancies (OR = 0.20, 95% CI 0.14-0.28) that was independent of age at last full-term pregnancy. Incomplete pregnancy was also associated with decreased endometrial cancer risk (7%-9% reduction per pregnancy). Twin births appeared to have the same effect as singleton pregnancies. Our pooled analysis shows that, while the magnitude of the risk reduction is greater for a full-term pregnancy than an incomplete pregnancy, each additional pregnancy is associated with further reduction in endometrial cancer risk, independent of age at last full-term pregnancy. These results suggest that the very high progesterone level in the last trimester of pregnancy is not the sole explanation for the protective effect of pregnancy.

Indexed as

Case-Control StudiesEndometrial NeoplasmsFemaleHumansPregnancyPregnancy OutcomeRisk Factorsendometrial cancerinduced abortionmiscarriageparitysex of offspring

Identifiers

PMID33105052
PMCPMC7969437
OpenAlexW3093643451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.